synvest-1
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 18, 2024 (NCT05360082)
Timeline
No events for the selected filters.
Mechanism of action
- Synaptic vesicle glycoprotein 2ARadiopharmaceutical
SV2A radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05360082 | N/A | Nov 18, 2024 | CHDI Foundation, Inc., Katholieke Universiteit Leuven |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CHDI Foundation, Inc. | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1